Fig. 2.
Recombinant-derived ARG531HISdemonstrates a similiar phenotype to describedARG531HIS patient plasmas. Plasma activity data were derived from the HAMSTeRS hemophilia A mutation database for all reported patients identified with ARG531HIS for which both one-stage (▪) and two-stage (□) results were available. The data from recombinant-derived ARG531HISwere obtained from assaying the activity in the conditioned medium from four independent transfection experiments. Activity forARG531HIS patient plasmas and recombinant-derived ARG531HIS is presented as the percentage of wild-type (normal plasma or recombinant FVIII WT, respectively).